A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy

摘要

Aims In-stent restenosis is a complication after coronary stenting associated with morbidity and mortality. Here, we sought to investigate the molecular processes underlying neointima formation and to identify new treatment and prevention targets.